Resistive Exercise for Arthritic Cartilage Health (REACH)

Sponsor
University of Sydney (Other)
Overall Status
Unknown status
CT.gov ID
NCT00465660
Collaborator
(none)
60
1
51
1.2

Study Details

Study Description

Brief Summary

Female subjects over the age of 40 will be recruited and randomised into a progressive resistance training (PRT) or sham-exercise group. The PRT group will train at 80% of their peak strength, using Keiser pneumatic resistance machines, and progress approximately 3% per session. Strength will be re-assessed fortnightly. Exercises will target muscles around the hip and knee. The sham-exercise group will train on the same equipment as the PRT group except hip adduction, but without added resistance or progression. Both groups will train 3 days per week for roughly 45 minutes for 6 months.

It is hypothesised that high intensity PRT will decelerate the tibial and femoral cartilage degeneration in the knee affected most by OA.

Primary Outcome:

Articular cartilage morphology following 6 months high intensity progressive resistance training

Secondary Outcomes:

Muscle and fat cross-sectional area (CSA) (pre and post) Muscle strength, power, endurance, and contraction velocity (pre, 3 months, & post) Medications (pre, 3 months, & post) Body composition (pre, 3 months, & post) Balance; Physical function (pre, 3 months, & post) Questionnaires (pre, 3 months, & post)

  • Habitual exercise (PASE) -WOMAC index (pain, stiffness and functional ability)

  • Depressive symptoms (Depression Scale) -Quality of life (SF36)

  • Confidence performing physical activity (Ewart) -Demographics

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Progressive resistance training
Phase 2

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
The Effect of 6 Month High Intensity Progressive Resistance Training on Knee Articular Cartilage Morphology in Female Osteoarthritic Patients
Study Start Date :
Apr 1, 2005
Study Completion Date :
Jul 1, 2009

Outcome Measures

Primary Outcome Measures

  1. Articular cartilage morphology following 6 months high intensity progressive resistance training []

Secondary Outcome Measures

  1. Muscle and fat cross-sectional area (CSA) (pre and post) []

  2. Muscle strength, power, endurance, and contraction velocity (pre, 3 months, & post) []

  3. Medications (pre, 3 months, & post) []

  4. Body composition (pre, 3 months, & post) []

  5. Balance; Physical function (pre, 3 months, & post) []

  6. Questionnaires (pre, 3 months, & post): []

  7. Habitual exercise (PASE) []

  8. WOMAC index (pain, stiffness and functional ability) []

  9. Depressive symptoms (Depression Scale) []

  10. Quality of life (SF36) []

  11. Confidence performing physical activity (Ewart) []

  12. Demographics []

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Female

  • Aged over 40 years old

  • Primary Osteoarthritis in at least one knee using standard criteria of the American College of Rheumatology (ACR) criteria for classification of clinical osteoarthritis

  • Ambulatory without human assistance

  • Willingness to be randomised to experiential or control group

  • Ability to attend scheduled exercise and testing sessions

Exclusion Criteria:
  • Regular exercise of any kind over the past 3 months (>1dpw).

  • Secondary osteoarthritis (traumatic or post-surgical), rheumatic disease, gouty or septic arthritis, Paget's disease, pseudogout, major congenital abnormalities, hemochromatosis, Wilson's disease and other rare forms of arthritis

  • Joint injury, injection or surgery within the past 6 months or knee joint replacement

  • Contraindications to MRI/Exercise

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Sydney Sydney New South Wales Australia 2140

Sponsors and Collaborators

  • University of Sydney

Investigators

  • Principal Investigator: Benedicte Vanwanseele, PhD, University of Sydney

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00465660
Other Study ID Numbers:
  • ACTRN012605000116628
First Posted:
Apr 25, 2007
Last Update Posted:
Apr 25, 2007
Last Verified:
Dec 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 25, 2007